Science ❯ Neuroscience

Psychedelics

Psilocybin Brain Function Therapeutic Applications DMT Brain Imaging Brain Activity Therapeutic Effects Therapeutic Use Drug Development Research Methods

Single Psilocybin Dose Shows Rapid Antidepressant Effect in Phase 2 Trial

Early findings raise hope for faster care pending confirmation in larger, longer studies.

Stories older than 24h

Single High Dose of Psilocybin Tied to Lasting Brain Changes and Month-Later Well-Being

Mega-Analysis Maps Common Brain Signature Across Psychedelics

Largest Brain-Scan Analysis Finds Shared Psychedelic ‘Neural Fingerprint’

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

Single Psilocybin Dose Rewires Brain-Wide Circuits in Mice, Cell Study Finds

DMT Pushes Brain Away From Critical Balance, Study Finds

Psychedelic DOI Reverses Synaptic Polarity in Claustrum-to-ACC Circuit

Australian Trial Finds Psilocybin Therapy Eases End-of-Life Depression and Anxiety

Psilocybin Extends Lifespan in Cells and Mice and Paves Way for Human Trials

CBP Seizes 695 Pounds of DMT in Baltimore, Prompting Federal Inquiry

New Zealand Greenlights Restricted Psilocybin Therapy for Treatment-Resistant Depression

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients

Psychedelic Research Advances Toward Non-Hallucinogenic Anxiety Treatments

Psilocybin Reduces Symptoms of Body Dysmorphic Disorder in Pilot Study